Cowen Financial Products Divests Entire Cresco Labs Stake
Ticker: CRLBF · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 1832928
| Field | Detail |
|---|---|
| Company | Cresco Labs Inc. (CRLBF) |
| Form Type | SC 13G/A |
| Filed Date | Feb 2, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-selling, divestment, ownership-change
TL;DR
**Cowen Financial Products sold all its Cresco Labs shares.**
AI Summary
Cowen Financial Products LLC, a New York-based financial entity, filed an amended SC 13G/A on February 2, 2024, indicating they no longer beneficially own any shares of Cresco Labs Inc. common stock as of December 29, 2023. This update shows a complete divestment from their previous holdings. For investors, this means a significant institutional holder has exited their position, which could signal a lack of confidence or a strategic portfolio reallocation.
Why It Matters
This filing indicates a major institutional investor, Cowen Financial Products LLC, has sold all its shares in Cresco Labs Inc., potentially signaling a bearish outlook or a shift in their investment strategy.
Risk Assessment
Risk Level: medium — The complete divestment by an institutional investor like Cowen Financial Products LLC could indicate underlying concerns about Cresco Labs Inc.'s future performance.
Analyst Insight
Investors should research why Cowen Financial Products LLC fully divested from Cresco Labs Inc. and consider if this signals broader concerns about the company or the cannabis sector.
Key Numbers
- 0 — Aggregate Amount Beneficially Owned (Cowen Financial Products LLC now owns zero shares of Cresco Labs Inc.)
- 0 — Percent of Class (Cowen Financial Products LLC's ownership percentage of Cresco Labs Inc. common stock)
Key Players & Entities
- Cowen Financial Products LLC (company) — the reporting person that filed the SC 13G/A
- Cresco Labs Inc. (company) — the subject company whose securities are being reported
- December 29, 2023 (date) — the date of the event requiring the filing
- February 2, 202 4 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- Other institutional investors may re-evaluate their positions in Cresco Labs Inc. following Cowen Financial Products LLC's complete divestment. (Cresco Labs Inc.) — medium confidence, target: Q1 2024
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A is an amendment filed by Cowen Financial Products LLC to update their beneficial ownership of Cresco Labs Inc. common stock, specifically indicating a change from a previous filing.
Who is the reporting person in this filing?
The reporting person is Cowen Financial Products LLC, located at 599 Lexington Avenue, New York, NY 10022.
What is the subject company of this filing?
The subject company is Cresco Labs Inc., with its business address at 400 W Erie St Suite 110, Chicago, IL 60654.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 29, 2023.
How many shares of Cresco Labs Inc. does Cowen Financial Products LLC now beneficially own?
As of December 29, 2023, Cowen Financial Products LLC beneficially owns 0 shares of Cresco Labs Inc. common stock, as indicated by 'AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0' in the filing.
Filing Stats: 914 words · 4 min read · ~3 pages · Grade level 8.3 · Accepted 2024-02-02 12:18:02
Filing Documents
- crlbfa3_20224.htm (SC 13G/A) — 25KB
- 0001085146-24-000641.txt ( ) — 27KB
(a)
ITEM 1(a). NAME OF ISSUER: Cresco Labs Inc.
(b)
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 400 W. Erie Street Suite 110 Chicago, IL 606054
(a)
ITEM 2(a). NAME OF PERSON FILING: Cowen Financial Products LLC
(b)
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 599 Lexington Ave. New York, NY 10022
(c)
ITEM 2(c). CITIZENSHIP: USA
(d)
ITEM 2(d). TITLE OF CLASS OF SECURITIES: common stock
(e)
ITEM 2(e). CUSIP NUMBER: 2258m106 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 0 (b) Percent of class: 0 (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Cowen Financial Products LLC : 0 (ii) shared power to vote or to direct the vote: Cowen Financial Products LLC : (iii) sole power to dispose or direct the disposition of: Cowen Financial Products LLC : 0 (iv) shared power to dispose or to direct the disposition of: Cowen Financial Products LLC : ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reporting perso